1. Home
  2. SNSC vs HBIO Comparison

SNSC vs HBIO Comparison

Compare SNSC & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SNSC

SunScout Holding Limited Class A Ordinary Shares

HOLD

Current Price

$0.40

Market Cap

26.9M

Sector

N/A

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

SELL

Current Price

$8.75

Market Cap

26.5M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
SNSC
HBIO
Founded
1998
1901
Country
New Zealand
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
26.9M
26.5M
IPO Year
2026
2000

Fundamental Metrics

Financial Performance
Metric
SNSC
HBIO
Price
$0.40
$8.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 55.7K
28.4K
Earning Date
12-01-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $116,176,000.00
Revenue This Year
N/A
$4.09
Revenue Next Year
N/A
$5.22
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.21
$0.40
52 Week High
$3.15
$10.20

Technical Indicators

Market Signals
Indicator
SNSC
HBIO
Relative Strength Index (RSI) 27.35 49.49
Support Level $0.21 $8.01
Resistance Level $1.10 $10.20
Average True Range (ATR) 0.18 0.58
MACD -0.01 -0.05
Stochastic Oscillator 24.62 29.04

Price Performance

Historical Comparison
SNSC
HBIO

About SNSC SunScout Holding Limited Class A Ordinary Shares

SunScout Holding Ltd is a clean-technology company engaged in the design, development, manufacturing, and commercialization of autonomous, solar-powered robotic mowers and related solar energy solutions. Its products are intended as alternatives to petrol-powered and grid-dependent electric lawn mowing equipment. The company's business comprises three lines of products and solutions, which are also its reportable segments: SunScout Products, Solar Power Development Solutions, and Engineering Products and Services. The majority of revenue is derived from the Solar Power Development Solutions segment, which develops and installs solar-energy systems for commercial, industrial, and institutional customers through EPC contracts. Geographically, maximum revenue is derived from New Zealand.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: